Dr. Brent Forester's presentation at the Massachusetts Medical Society Sixth Annual Meeting

Identification and Treatment of Bipolar Disorder and Schizophrenia in the Long-Term Care Setting

Welcome to the Massachusetts Medical Directors Association's Web Site

The aim of this web site is to keep current and potential members up-to-date on pertinent chapter activities and on local and national issues in Long Term Care.  Your input and involvement is welcome.  This site will post original materials along with links to existing resources, tools,  articles and legislative information that we hope will help advance our mission and to improve patient care and promote the professional development of long term care medical directors.  We are here to help you provide the compassionate, quality care all long term care residents deserve.

MMDA members can submit non-commercial long term care related items for possible future posting to this website.  Interested members can send an email to mamdawebsite@gmail.com.

Medical Orders for Life-Sustaining Treatment (MOLST) Implemented Across Massachusetts

In accordance with recommendations by the Massachusetts Department of Public Health and the Massachusetts Expert Panel on End-of-Life Care, health care institutions throughout the Commonwealth have begun implementing the MOLST process and form. Click here for February update.

MOLST Reminder

Dr. Madeleine Biondolilo, Director, Bureau of Health Care Safety and Quality, sends reminder about MOLST.  Click here to read reminder.

Dementia Special Care Unit Draft Regulations Summary

 Click here to download summary.

MAMDA and Masspro Advisory Board

Click here to read about MAMDA participation on the Masspro Advisory Board.

Massachusetts Medical Directors Association
Regulatory, Payment and Quality Issues in Long Term Care

Click here to view photos from this year's meeting.

AMDA Certification Program Application Deadline

The next deadline for applications for initial or recertification as a Certified Medical Director is October 1.  Download your application online at www.amda.com/certification/process.cfm.  For questions about the AMDA Certification Program (AMDCP) contact the Program Manager at sharris@amda.com or 410-992-3117.

DEA Issues Statement on Authorized Agents for Schedule III-V Controlled Substances

The Drug Enforcement Administration (DEA) issued a 5-page Statement of Policy on the Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies at http://edocket.access.gpo.gov/2010/pdf/2010-25136.pdf. The DEA Statement provides an example of a written agreement that would confer authority to an agent to act on behalf of an individual practitioner with regard to controlled substance prescriptions. In the Statement, the DEA states "where a DEA-registered individual practitioner has made a valid oral prescription for a controlled substance in Schedules III-V by conveying all the required prescription information to the practitioner's agent, that agent may telephone the pharmacy and convey that prescription information to the pharmacist." This does not apply to Schedule II controlled substances. The Statement adds "An agent may not call in an oral prescription for a Schedule II controlled substance on behalf of a practitioner even in an emergency circumstance."

Individual practitioners may choose to designate and authorize one or more persons at one or more locations within or outside their practice to act as their agent. Likewise, an individual may act as an authorized agent for multiple individual practitioners depending upon the circumstances. A sample agreement designating the agent of practitioner for communicating controlled substance prescriptions to pharmacies is provided in the Statement.

AMDA staff is reviewing the Statement and will publish more details shortly. In addition, AMDA continues to partner with other associations to provide guidance to our respective memberships.

To read the DEA Statement, click here.

Free Resource: Tip Sheet on Controlled Substance Prescribing in LTC

Medical societies seeking to ensure compassionate and high quality care for long term care patients joined together to develop a "Tip Sheet on Prescribing for Controlled Substances in Long Term Care." The document is designed to assist physicians and other prescribers in their efforts to ensure proper controlled substances prescribing in long term care, and deal with aggressive enforcement actions by Drug Enforcement Administration agents. View Tip Sheet

CDC 2010-2011 Influenza Updates

Click here to go to the CDC website for information on the 2010-2011 Flu Season.

AMDA Distance Learning Opportunities Now Available Online

AMDA has expanded their online and distance learning offerings.  This year AMDA has embarked on an expansion of their distance learning program.  Adding live webinars, recorded webcasts and bringing back CME credits on revised CPGs, AMDA's education outreach continues to grow to meet the needs of practitioners in the long term care setting.  Participants can earn both CME credits and CMD credits for these educational activities which are now available to you at the click of a mouse.  This is a fantastic opportunity to get long term care specific education without the need to book flights or take time away from your busy practice.

Recently added CME activities include education on practice management, billing and coding in long term care and revised CPGs on COPD, Heart Failure and Parkinson's Disease in the long term care setting.  Whether you are new to the long term care setting, or if you have year's of long term care practice experience, AMDA has put together these CME activities to keep you up to date on clinical and management areas important to your long term care practice.

Visit AMDA's website today to learn about their expanding offerings in distance education.

Click Here To Learn More and Register